Acadia Pharmaceuticals Inc
NASDAQ: ACAD
$16.37
+$0.19 (+1.2%)
Closing Price on November 22, 2024
ACAD Articles
Acadia Pharmaceuticals reported its second-quarter financial results after the markets closed on Tuesday.
Published:
Last Updated:
After Acadia Pharmaceuticals released its third-quarter earnings report after the markets closed on Monday, shares rose sharply Tuesday morning.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include AT&T, CenturyLink, Goldman Sachs, OneMain and Priceline.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include CenturyLink, Gold Fields, Papa John's, Priceline, SolarCity, Tesla Motors and Unisys.
Published:
Last Updated:
A Merrill Lynch report has a whole wave of companies featured as Global Ageing Primer Picks, including these biotech and pharmaceutical picks.
Published:
Last Updated:
Despite the fact that first-quarter earnings will come in big next week, some serious insider buying has hit the tape.
Published:
Last Updated:
Over the past week, Opko Health, Acadia Pharmaceuticals and a few other biotech companies made impressive runs.
Published:
Last Updated:
Acadia Pharmaceuticals saw its shares on the rise again this week following an incredibly positive FDA vote on its Parkinson's treatment.
Published:
Last Updated:
Shares of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) surged early on Monday morning. This company is under the spotlight by the U.S. Food and Drug Administration’s Psychopharmacologic Drugs...
Published:
Last Updated:
24/7 Wall St. has collected three big FDA decisions coming up in March and added some color, along with the trading range and price target.
Published:
Last Updated:
Here are six biotech and pharma stocks that analysts are telling their firm's clients to buy now for solid upside opportunities ahead.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday, February 8 include Athenahealth, Baker Hughes, Cisco, LinkedIn, Orbital-ATK and Tableau Software.
Published:
Last Updated:
Thursday's top analyst upgrades, downgrades and initiations include Amazon.com, Monsanto, Schlumberger, SolarCity, Western Digital, Yelp, Abercrombie & Fitch.
Published:
Thursday's top analyst upgrades, downgrades and initiations include Alcatel-Lucent, Apple, Coach, Etsy, Intel, MannKind, Netflix, SanDisk and Starbucks.
Published:
Here are the five biotech stocks that are loved the most by portfolio managers, according to Cowen analysts.
Published: